Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01101360 · ClinicalTrials.gov registry record · NA

Port Wine Stains Treatment Matrix RF Study

A NA study, sponsored by Syneron Medical.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01101360: Completed NA study, sponsored by Syneron Medical.

NCT01101360 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01101360, a NA study, has completed, sponsored by Syneron Medical.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy and safety of the Matrix RF for Port Wine Stains based on clinical and histological analyses.

Primary Outcome

Assess safety of the Matrix RF treatment for port wine stains

Interventions

  • DEVICE Matrix RF
  • DEVICE Matrix RF followed by Pulse Dye Laser
  • DEVICE Pulse Dye Laser followed by Matrix RF

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-03
Phase NA
Syneron Medical

18 total trials

What the finished NCT01101360 record still lists

NCT01101360 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Matrix RF is the first listed.

NCT01101360 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01101360 about?

NCT01101360 is a clinical study titled "Port Wine Stains Treatment Matrix RF Study". The purpose of this study is to evaluate the efficacy and safety of the Matrix RF for Port Wine Stains based on clinical and histological analyses.

What is the current status of trial NCT01101360?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-03.

What interventions are being tested in trial NCT01101360?

The interventions under investigation include: Matrix RF (DEVICE), Matrix RF followed by Pulse Dye Laser (DEVICE), Pulse Dye Laser followed by Matrix RF (DEVICE).

Who is sponsoring clinical trial NCT01101360?

This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01101360's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01101360, the US trial registry maintained by the National Library of Medicine. NCT01101360 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.